We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDPH
RNS Number : 1712R
Dechra Pharmaceuticals PLC
19 September 2017
19 September 2017
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Dechra Pharmaceuticals PLC announces that on 19 September 2017, the following PDMRs exercised nil cost options over ordinary shares of 1p each in the Company. The options were granted to them on 15 September 2014 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP). The exercise of the options was subject to the achievement of performance conditions which vested at 100% of the total award.
Name Capacity Options Exercised Total beneficial Percentage shareholding of issued following share this announcement capital Ian Page Director 115,334 792,142 0.848% Tony Griffin Director 29,937 94,257 0.101%
The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") --- ---------------------------------------------------------------- a) Name Ian Page --- ----------------------------- --------------------------------- 2. Reason for the notification --- ---------------------------------------------------------------- a) Position/status Director/PDMR --- ----------------------------- --------------------------------- b) Initial notification/ Initial Notification amendment --- ----------------------------- --------------------------------- 3. Details of the Issuer --- ---------------------------------------------------------------- a) Name Dechra Pharmaceuticals PLC --- ----------------------------- --------------------------------- b) LEI code N/A --- ----------------------------- --------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ---------------------------------------------------------------- a) Description Ordinary Shares of 1 pence of the financial each instrument Identification ISIN: GB0009633180 code --- ----------------------------- --------------------------------- b) Nature of Exercise of 115,334 options the transaction under the Company's Long Term Incentive Plan --- ----------------------------- --------------------------------- c) Price(s) and Price(s) Volume(s) volumes(s) GBPNil Cost 115,334 --- ----------------------------- ------------------ ------------- d) Aggregated information * Aggregate volume N/A * Price --- ----------------------------- --------------------------------- e) Date of the 2017.09.15 transaction --- ----------------------------- --------------------------------- f) Place of the Outside a trading venue transaction --- ----------------------------- --------------------------------- 1. Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") --- ----------------------------------------------------------------- a) Name Tony Griffin --- ------------------------------ --------------------------------- 2. Reason for the notification --- ----------------------------------------------------------------- a) Position/status Director/PDMR --- ------------------------------ --------------------------------- b) Initial notification/ Initial Notification amendment --- ------------------------------ --------------------------------- 3. Details of the Issuer --- ----------------------------------------------------------------- a) Name Dechra Pharmaceuticals PLC --- ------------------------------ --------------------------------- b) LEI code N/A --- ------------------------------ --------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------------- a) Description Ordinary Shares of 1 pence of the financial each instrument Identification ISIN: GB009633180 code --- ------------------------------ --------------------------------- b) Nature of Exercise of 29,937 options the transaction under the Company's Long Term Incentive Plan --- ------------------------------ --------------------------------- c) Price(s) and Price(s) Volume(s) volumes(s) GBPnil 29,937 --- ------------------------------ --------------- ---------------- d) Aggregated information * Aggregate volume N/A * Price --- ------------------------------ --------------------------------- e) Date of the 2017.09.15 transaction --- ------------------------------ --------------------------------- f) Place of the Outside a trading venue transaction --- ------------------------------ ---------------------------------
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHOKCDBKBKDCCD
(END) Dow Jones Newswires
September 19, 2017 06:30 ET (10:30 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions